Introduction
The mammalian Ras proteins are small (21 kDa) membrane-associated guanine-nucleotide binding proteins, which are encoded by three dierent genes (Hras, K-ras, and N-ras). They link receptor tyrosine kinases and G protein-coupled receptors to downstream signaling events (Khosravi-Far et al., 1998) . Ras cycles between an active GTP-bound and an inactive GDP-bound form ( Boguski and McCormick, 1993) . Activated Ras proteins are involved in regulating various cellular processes, such as proliferation, dierentiation, changes of cell morphology or apoptosis (Downward, 1998; Lowy and Willumsen, 1993) . Intracellular signals are transmitted from Ras to numerous eector molecules, which activate dierent signal transduction cascades. The individual cellular consequences, however, are dependent on cell type and on the activated signal transduction pathway (Khosravi-Far et al., 1998; Marshall, 1996) . It is well established, that GDP-GTP exchange on Ras is stimulated by receptor tyrosine kinases, such as the EGF receptor ( Buday and Downward, 1993) . Activated Ras associates with the serine-threonine kinase Raf (Avruch et al., 1994) . Raf in turn transmits the signal via phosphorylation to MEK (MAPK or ERK kinase) (Huang et al., 1993) , which subsequently phosphorylates its downstream eector MAPK (mitogen-activated protein kinase). Phosphorylated MAPK binds to other kinases (Sturgill et al., 1988) and translocates into the nucleus where it interacts with dierent transcription factors (Seth et al., 1992; Treisman, 1996) , demonstrating its role in the regulation of growth factor-induced gene expression.
The signi®cance of the Ras-Raf-MEK-MAPK pathway is emphasized by the fact that several components of the pathway are oncogenic in their constitutively activated form (Seger and Krebs, 1995) . Indeed, Ras and Raf were originally identi®ed as viral oncogenes before their cellular counterparts were discovered (Bonner et al., 1985; Chang et al., 1982) . Mutated versions of ras genes have been detected in more than 30% of all human cancers, although the frequency varies with respect to tumor type. Cancer of the pancreas is the human tumor with the highest incidence of ras mutations, indicating that aberrant Ras function may contribute to the development of pancreatic neoplasms (Bos, 1989; Cox and Der, 1997) . In human pancreatic adenocarcinoma nearly all ras-mutations are localized in the K-ras gene (Hruban et al., 1993) . Although activating K-ras mutations are thought to be involved in carcinogenesis, it is still unclear, in which genetic context they occur and which precise role they play in signal transduction and proliferation control (Brat et al., 1997; Caldas and Kern, 1995) . Studies in ®broblasts demonstrated that overexpression of activated Ras proteins uncouples growth factor receptors from Ras activation and results in increased MAPK activity (Hattori et al., 1992; Satoh et al., 1990) . Therefore, it is conceivable that the activating point mutation in codon 12 of the K-ras gene in pancreatic carcinoma cell lines leads to constitutive activation of downstream signal transduction elements, such as Raf or MAPK. However, there are few reports about Ras-dependent or Ras-regulated signal transduction processes in human carcinoma cells carrying activated KRas.
In the current report we have analysed the activity of the Ras-Raf-MEK-MAPK signal transduction pathway in the pancreatic carcinoma cell line PANC-1 (Kras G12D) (Sumi et al., 1994) . The Ras-MAPK cascade was not constitutively activated in PANC-1 cells harboring an activated K-ras gene, but was activated upon treatment of serum-starved cells with FCS or EGF. Furthermore, the integrity of growth factorinduced signaling from Ras to MAPK was maintained in these cells. The level of activated K-Ras was not further enhanced by FCS or EGF treatment. In contrast, the level of GTP-bound N-Ras was markedly increased, identifying N-Ras as the Ras protein involved in growth factor-induced signaling in these cells. Activation of MAPK by EGF and other growth factors alone was not sucient to stimulate cell proliferation of serum-starved PANC-1 cells, but activated MAPK was necessary for FCS-induced proliferation. Importantly, treatment of serum-starved PANC-1 cells with EGF resulted in marked, MEKdependent stimulation of directed cell migration.
Results

MAP kinase activation in PANC-1 cells
To elucidate the eects of K-ras mutation on MAPK activity in PANC-1 cells, we analysed the kinase activity under dierent cell culture conditions. EGF represents a classical stimulator of the Ras-MAPK cascade (Buday and Downward, 1993) and most human pancreatic carcinoma cells are characterized by overexpression of EGF receptor and its ligands (data not shown, Friess et al., 1996) . We compared FCS-and EGF-induced activation of MAPK in PANC-1 cells. As demonstrated in Figure 1a , treatment of serum-starved PANC-1 cells with 10% FCS caused activation of MAPK as measured by in vitro phosphorylation of MBP-peptide. MAPK activation was evident as early as 1 min after serum addition with a maximum at approximately 10 min and decreased during prolonged treatment. A similar time-course was obtained by activation of the EGF receptor tyrosine kinase with EGF ( Figure 1b) . Maximal MAPK phosphorylation of MBP-peptide was achieved approximately 10 min after EGF addition. Equal MAPK content in the analysed samples was con®rmed by immunoblot analysis using the same MAPK antibody as for immunoprecipitation. This antibody predominantly reacts with the p42 MAPK isoform. These results clearly revealed that MAPK is markedly activated by external stimuli, despite the presence of an activating K-ras mutation.
In an additional set of experiments (Figure 1c ), the eect of EGF on MAPK activity of PANC-1 cells, grown continuously in 10% FCS was analysed. Five minutes after addition of EGF both serum-starved cells and cells grown in 10% FCS exhibited an approximate 30-fold activation of MAPK. Addition of 10% FCS to serum-starved cells resulted in an approximate 15-fold stimulation of MAPK activity. These data show that incubation of cells for 24 h in medium with 10 or 0.1% FCS did not alter the ability of EGF to act as an ecient MAPK stimulator. Interestingly, persistent incubation of PANC-1 cells in 10% FCS resulted only in a minor, if any, increase of basal MAPK activity. To address the question, whether basal MAPK activity re¯ects constitutively elevated MAPK activity caused by the mutated K-Ras protein, BxPC-3 pancreatic carcinoma cells (see also Figures 2c and 6c) (Tan et al., 1986; Yip-Schneider et al., 1999) and NIH3T3 cells, both carrying only wild-type K-Ras, were analysed under the same conditions. No dierences were detected in kinase activity between PANC-1, BxPC-3 and NIH3T3 cells (data not shown). These results raise two important points: First, activation of MAPK by serum or EGF is maintained in PANC-1 cells, regardless of the K-ras mutation. Second, MAPK is not constitutively activated, neither in PANC-1 cells grown in medium with 0.1% FCS nor in medium containing 10% FCS, i.e. under conditions of exponential cell growth. The latter result point towards a downregulation of MAPK activity under these growth conditions in 10% FCS.
EGF-and FCS-induced activation of MEK in PANC-1 cells
Activation of MAPK requires the phosphorylation of both threonine and tyrosine residues within TEY tripeptide (Payne et al., 1991) by a dual-speci®city kinase, MAP kinase kinase, also referred to as MEK. To clarify whether MAPK activation induced by FCS or EGF is mediated by MEK, we analysed activity of this kinase under conditions used for MAPK assays (Figure 2a ). Kinase activity of PANC-1 cells maintained in 0.1% FCS (lane 3) was considerably increased by addition of 10% FCS (lane 4). An even more pronounced enhancement of MEK-1 activity was detected after EGF treatment (lane 6). Densitometric analysis of the autoradiography revealed an approximate ®vefold increase of MEK-1 activity after serum addition and a sevenfold increase after EGF addition, respectively. The MEK-1 inhibitor PD98059, which binds selectively to the inactive form of MEK-1 and prevents its activation by upstream activators such as c-Raf-1 (Dudley et al., 1995) , caused a distinct inhibition of growth factor-induced kinase activity (lanes 5 and 7). Figure 2b illustrates the eects of MEK-1 inhibition on FCS-or EGF-induced MAPK activation in PANC-1 cells. Preincubation of serumstarved cells with PD98059 prior to addition of FCS or EGF completely abolished MBP-peptide phosphorylation. Similar results were obtained for BxPC-3 pancreatic carcinoma cells (Figure 2c ). Addition of EGF to serum-starved BxPC-3 cells caused a nearly ®vefold activation of MAPK, which was inhibited by preincubation of cells with the MEK-inhibitor. These experiments provide direct evidence that MEK is required for growth factor-induced activation of MAPK in both, K-ras mutated PANC-1 and K-ras non-mutated BxPC-3 cells.
MAP kinase activation by mutationally activated K-Ras
To elucidate whether mutationally activated K-Ras, KRas (G12V), is able to activate MAPK in PANC-1 cells, MAPK activity was analysed in serum-starved PANC-1 cells transiently transfected with hemagglutinin (HA)-tagged MAPK and either wild-type K-Ras (G12) or constitutively activated K-Ras (G12V). As shown in Figure 3 , transfection of PANC-1 cells with pcDNA3/HA-MAPK and pcDNA3.1/K-Ras (G12) did not aect HA-MAPK activity as compared to mocktransfected controls. In contrast, constitutively active K-Ras (G12V) brought about a sevenfold activation of HA-MAPK activity in serum-starved cells. These results demonstrate, that mutationally activated KRas is capable of activating the MAPK-pathway in PANC-1 cells.
c-Raf-1 activation by FCS and EGF
The in¯uence of FCS and EGF on the activity of cRaf-1 was measured by in vitro phosphorylation using recombinant polyhistidine-tagged mouse MEK-1 and kinase-inactive mouse MAPK as substrates for immunoprecipitated c-Raf-1. The results of one representative experiment out of three assays are shown in 
Activation of Ras by EGF
The results presented thus far demonstrate that the mutated K-ras gene in PANC-1 cells does not lead to a constitutive activation of the Raf-MEK-MAPK cascade. Moreover, growth factors maintained their ability to stimulate the kinases. These ®ndings raised the intriguing question, whether Ras is involved in mediating activation of these kinases, or whether Ras-independent events are responsible for kinase activation. To measure activation of endogenously expressed Ras in PANC-1 cells, the Ras binding domain (RBD) of c-Raf was expressed as a GSTfusion protein in E. coli and used as an activation speci®c probe for GTP-bound Ras (de Rooij and Bos, 1997; Herrmann et al., 1995) . Figure 5 represents a typical time-course of EGF-induced Ras activation of serum-starved PANC-1 cells. The maximal amount of Ras-GTP was detected approximately 5 min after EGF addition, resulting in 3.5-fold activation with regard to serum-starved cells. Ras activity returned to its initial level after 15 min. The data presented so far revealed that the entire cascade from Ras to MAPK is activated by EGF.
Detection of Ras isoform-specific activation by FCS or EGF
To analyse the activation of dierent Ras isoforms and the proportion of activated K-Ras before and after growth factor addition in more detail. We ®rst investigated the expression of the individual Ras isoforms both on mRNA and protein level. Total mRNA of exponentially grown PANC-1 cells was used to synthesize cDNA for RT ± PCR analysis. As shown in Figure 6a ampli®cation of H-ras, N-ras and K-ras 4B resulted in a 603 bp PCR-products, encoding the complete coding sequences. The K-ras 4A product was 42 nucleotides shorter than K-ras 4B, because this antisense primer hybridized within exon 4A and not after the stop codon Shimizu et al., 1983) . Moreover, Figure 6 shows that similar amounts of transcripts for all four Ras isoforms were detected in PANC-1 cells and also in BxPC-3 cells. To control the amount of cDNA used in the reaction a fragment of b-actin was also ampli®ed.
Protein expression of Ras isoforms was analysed in lysates of PANC-1 and BxPC-3 cells using isoform speci®c antibodies (Figure 6b ). K-Ras and N-Ras were easily detected, whereas H-Ras was poorly visualized in both pancreatic cell lines. To con®rm these results, we used high resolution tricine-SDS- (Cox et al., 1995) as well as two-dimensional gel electrophoresis to separate Ras isoforms. Both methods gave very similar results, K-Ras and N-Ras were clearly detectable, whereas H-Ras was only poorly visible even upon loading very high quantities of sample protein, regardless of the antibody used (data not shown).
To analyse, whether one or both K-Ras alleles in the used PANC-1 cells were mutated, we performed single nucleotide primer extension (SNuPE) assays, using . PD98059 (25 mM) was added for 15 min (lanes 5 and 7), controls were treated with solvent. Cells were then treated for 5 min with either 10% FCS (lanes 4 and 5) or 30 ng/ml EGF (lanes 6 and 7). MEK-1 was immunoprecipitated from RIPA extract (1 mg of protein) and the kinase activity was examined by using kinase-inactive recombinant MAPK as substrate. Proteins were subjected to 7.5% SDS ± PAGE and the phosphorylated products were visualized by autoradiography. Immunoblot analysis of one third of the MEK-1 immunoprecipitates is shown in the lower panel. (b, c) MAPK activity. PANC-1 (b) and BxPC-3 (c) cells were cultured for 24 h in DMEM+0.1% FCS and then incubated for 15 min with PD98059 (25 mM). Growth factors, either 10% FCS (PANC-1) or 30 ng/ml EGF (PANC-1 and BxPC-3), were added for 5 min. MAPK was immunoprecipitated from 1 mg of cytosolic protein and the kinase activity analysed as described in Materials and methods using MBP peptide as substrate. Phosphorylation was quanti®ed by the Cerenkov method. One representative experiment out of three to ®ve assays with mean values of duplicates is shown. Open bar: MAPK activity in 0.1% FCS, solid bars: MAPK activities after treatment with 10% FCS or 30 ng/ml EGF, cross-hatched bars: MAPK activity after pretreatment with 25 mM PD98059. The inset illustrates the corresponding immunoblot of aliquots of the MAPK immunoprecipitates, stained with anti-ERK 2 (C-14) antibody non-mutated BxPC-3 cells, as well as K-Ras (G12) and K-Ras (G12D) cDNA as controls. Figure 6c shows that mRNA encoding wild-type K-Ras (G12) and activated K-Ras (G12D) are equally abundant in PANC-1 cells. In contrast, BxPC-3 cells only contained mRNA encoding wild-type K-Ras. Cloning and sequencing of 12 individual K-Ras PCR products of PANC-1 cells revealed that products encoding K-Ras (G12) and K-Ras (G12D) were present at a ratio of 5 : 7, con®rming the proportion found in SNuPE assays.
Since there is growing evidence, that dierent Rasisoforms may be activated by dierent stimuli, we determined which Ras isoform was activated by FCS or EGF in PANC-1 cells ( Figure 7 ). Serum-starved PANC-1 cells were treated for 5 min with medium containing either 10% FCS or 30 ng/ml EGF. As shown in Figure 7 (left panel), quiescent PANC-1 cells incubated in medium with 0.1% FCS contained no GTP-bound H-Ras and only negligible GTP-bound NRas, but high levels of activated K-Ras. Addition of either FCS or EGF did not result in further activation of K-Ras. In contrast, the level of GTP-bound N-Ras markedly increased. Activation of H-Ras was not detectable, neither after FCS-nor after EGF-treatment. The sensitivities and speci®cities of the antisera used in this experiment were veri®ed by using recombinant, immunoprecipitated HA-tagged Ras proteins ( Figure 7 , right panel).
Taken together, these results show that, in our hands, N-Ras and K-Ras were abundantly expressed in PANC-1 cells, whereas H-Ras was present at very low levels, if at all. K-Ras was expressed both as wild-type and G12D mutant. The latter isoform most likely accounted for the activated K-Ras activity in serumstarved PANC-1 cells. Addition of growth factors, such as FCS or EGF, resulted in Ras-isoform speci®c activation of N-Ras.
MAP kinase activation by polypeptide growth factors
Since the PANC-1 epitheloid carcinoma cell line (Lieber et al., 1975) is characterized by overexpression of the EGF receptor and its ligands, one could speculate that activation of the Ras-MAPK cascade is a unique phenomenon of EGF. We therefore compared the eects of several receptor tyrosine kinase agonists on stimulation of endogenous MAPK activity. Serum-starved PANC-1 cells were incubated for 10 min with 10 ng/ml of each growth factor and MAPK assays were performed. Figure 8 summarizes the results obtained. All polypeptide growth factors caused MAPK activation, although to a variable extent. EGF exhibited the highest degree of MAPK activation (approximately 14-fold), followed by FCS or TGFa (sevenfold), FGF-2 (®vefold) and HGF (fourfold). A less than threefold stimulation of MAPK activity was c-Raf-1 was immunoprecipitated from RIPA-cell lysates (2 mg of protein) and the kinase activity was determined as described in Materials and methods. Recombinant wt MEK-1 and kinaseinactive recombinant MAPK were used as substrates. Phosphorylated products were detected by subjecting the proteins to 7.5% SDS ± PAGE and autoradiography. The lower panel shows the cRaf-1 immunoblot of the corresponding immunoprecipitates. The results of one representative experiment out of three are shown Figure 5 Time-course of EGF-induced Ras activation. PANC-1 cells were grown for 18 h in DMEM+0.1% FCS and then treated for the indicated periods with 30 ng/ml EGF. Ras-GTP was recovered from 1 mg of cellular protein by using GST-RBD as an activation speci®c probe for endogenous Ras-GTP. Proteins were separated by 12.5% SDS ± PAGE and the amount of bound Ras-GTP was analysed by immunoblotting using pan-Ras (Ab-3) antibody. One representative blot of three is shown achieved by IGF-1 or PDGF-B. Although there are dierences in the stimulation of MAPK, these experiments show that the activation of MAPK is not limited to EGF, but is common for various polypeptide ligands of receptor tyrosine kinases.
Growth characteristics of PANC-1 cells
Next, the nutrient-and growth factor-requirement of the pancreatic carcinoma cell line PANC-1 was Lysates were separated by 12.5% SDS ± PAGE and transferred to nitrocellulose. Expression of individual Ras isoforms was determined by immunoblot analysis using anti H-Ras (F235), anti c-K-Ras (Ab-1) or anti c-N-Ras (Ab-1) antibody, respectively (c) Determination of K-Ras mutation at codon 12 by single-nucleotide primer extension. Total mRNA was prepared from PANC-1 and BxPC-3 cells and used as template for RT ± PCR using primers speci®c for K-Ras 4B. The ampli®ed cDNA fragments were fractionated by agarose (2%) gel electrophoresis, gel-puri®ed, and aliquots (20 ng/sample) were used as SNuPE templates. Single oligonucleotide primers, which bind immediately adjacent to the nucleotide dierences between K-Ras (G12) and K-Ras (G12D) (5'-ACTTGTGT-GAGTTGGAGCTG-3', nucleotides 15 ± 34) were extended by a single nucleotide in the presence of [ 32 P]dATP or [ 32 P]dGTP to obtain radiolabeled oligonucleotides corresponding to the mRNAs of K-Ras (G12) and K-Ras (G12D). Samples containing either no template cDNA (Control) or cDNA encoding K-Ras (G12) or K-Ras (G12D) (50 ng/sample) were analysed for comparison. Radiolabeled oligonucleotides were separated on denaturating 7 M urea-15% polyacrylamide gel and the bands visualized by autoradiography. One representative assay out of four individual experiments, using dierent RT ± PCR probes, is shown Figure 7 Detection of Ras isoform-speci®c activation in PANC-1 cells. Con¯uent PANC-1 cells were serum-starved for 24 h and stimulated with either 10% FCS or 30 ng/ml EGF for 5 min. Ras assays were performed using 5 mg of RIPA lysate and GST-RBD in pull-down experiments. Proteins were separated on 16.5% tricine-SDS-polyacrylamide gels and transferred to nitrocellulose. Precipitated Ras isoforms were detected using anti H-Ras (F235), anti c-K-Ras (Ab-1) or anti c-N-Ras (Ab-1) antibody, respectively. To examine antibody speci®city, HA-tagged H-Ras, KRas, or N-Ras was expressed in E. coli and immunoprecipitated from crude lysates using anti-HA (12CA) antibody (indicated as IgG). The slower migration of the recombinant proteins is due to the HA-tag and lack of posttranslational modi®cation. One representative assay out of three to six individual experiments is presented To investigate the requirement of serum factors for long-term culture, PANC-1 cells were incubated for 5 ± 10 days in medium with and without serum and counted. Figure 9a illustrates the cell growth of PANC-1 in medium with 10% FCS versus 0.1% FCS versus 0.1% FCS supplemented with 100 ng/ml EGF. In 10% FCS PANC-1 cells clearly showed cell proliferation with a doubling time of approximately 36 h. In contrast, long-term treatment (5 ± 10 days) of PANC-1 cells with medium with 0.1% FCS or 0.1% FCS+EGF caused cells to remain attached to the substrate but without proliferating. Thus, substratedependent growth of PANC-1 cells is dependent on the availability of growth factors. Interestingly, the addition of EGF did not result in cell proliferation.
One characteristic of transformed phenotype is the ability of cells to grow in a substrate-independent way. Substrate-independent cell growth of PANC-1 cells was analysed in soft-agar assays and the results obtained are presented in Figure 9b . Incubation of PANC-1 cells in 10% FCS resulted in formation of large colonies, which were visible already after 14 days. However, there was no colony development in medium with 0.1% FCS nor in medium supplemented with EGF. Thus, substrate-dependent and substrate-independent proliferation of PANC-1 cells requires serum components which cannot be replaced by EGF alone.
Because it is known that most growth factors stimulate DNA-synthesis only in speci®c, synergistic combinations (Rozengurt, 1986) , we analysed the eects of EGF on DNA-synthesis of PANC-1 cells in the presence and absence of insulin and transferrin. As illustrated in Figure 9c , addition of insulin and transferrin induced an approximately 75% increase in DNA-synthesis. Importantly, addition of EGF did not cause an increase in thymidine incorporation, regardless of the presence or absence of insulin and transferrin.
Since EGF and insulin/transferrin both activated MAPK (threefold activation by insulin/transferrin, data not shown), but only the latter stimulated DNA-synthesis, we compared the ability of various ligands to activate MAPK and stimulate DNAsynthesis in PANC-1 and NIH3T3 cells (Table 1) . Although EGF caused the most pronounced MAPK activation in both cell lines, it had no eect on DNAsynthesis in PANC-1 and only a minor eect, compared to FCS, in NIH3T3 cells. In both cell lines, TGFa stimulated MAPK activity, but did not alter cell proliferation. In contrast, HGF or IGF-1 were moderate stimulators of MAPK activation in PANC-1 cells, but the only growth factors which induced [ 3 H]thymidine incorporation after addition to serumstarved PANC-1 cells. We conclude from these results, that activation of MAPK in PANC-1 cells does not correlate with growth factor-induced DNA-synthesis.
To address the overall signi®cance of MAPK activation for growth factor-induced PANC-1 cell proliferation, the eect of the MEK-1 inhibitor 10% FCS ----+ Figure 9 (a ± c) In¯uence of EGF on substrate-dependent and substrate-independent cell growth. (a) Substrate-dependent cell growth. PANC-1 cells (2610 3 cells/35 mm dish) were cultured for 24 h in DMEM+10% FCS. Cells were then incubated for 7 days in DMEM with the indicated supplements: &10% FCS,~0.1% FCS,~0.1% FCS+100 ng/ml EGF. Every 12 h, the cells from three individual grids were counted. Mean values+s.e.m. of three independent experiments, expressed as cell number per well are shown. (b) Substrate-independent growth. Cells were plated at a density of 1610 4 cells per 6-well dish in DMEM+0.34% agar and the indicated supplements: 10% FCS, 0.1% FCS or 0.1% FCS+30 ng/ml EGF, respectively. Cells were incubated for 34 days and medium was changed every second day. The colony formation was monitored by photomicrography after 14 Figure 10b shows that addition of FCS and EGF caused an approximate ®ve-and fourfold, respectively, activation of cell migration through the porous membrane. Addition of PD98059 (25 mM) to the medium resulted in a 60% reduction of FCSinduced and complete loss of EGF-induced chemotaxis of PANC-1 cells (hatched bars). The spontaneous migration of cells in DMEM without supplements was also reduced by the MEK-1 inhibitor, albeit to a lower extent (38%). Similar results were observed for growth factor-induced migration of BxPC-3 pancreatic cells (data not shown).
These results demonstrate that the MAPK cascade is an important mediator in the regulation of cell proliferation and stimulation of both spontaneous and especially directed cell migration by growth factors, even in K-ras mutated PANC-1 cells.
Discussion
Pancreatic adenocarcinoma, the tumor with the highest incidence of K-ras point mutations (70 ± 90% of all cases) (Longnecker and Terhune, 1998) , is one of the leading causes of cancer death. There are numerous reports about the use of this mutation as a diagnostic marker for pancreatic cancer (Okada et al., 1998) and about the role of Ras proteins in human carcinogenesis (Cox and Der, 1997; Chin et al., 1999; Laird and Shalloway, 1997) . Although there are reports about the importance of mutated K-ras genes in cell growth (Kita et al., 1999) and tumor dissemination (Aoki et al., 1997) , the signal transduction pathways utilized by activated K-Ras in pancreatic carcinoma cells are poorly understood.
The Raf-MEK-MAPK pathway is one of the most thoroughly analysed eector pathways of Ras. The aim of this study was to analyse the activity and functional relevance of the Ras-Raf-MEK-MAPK signal transduction pathway in the human pancreatic carcinoma cell line PANC-1 upon treatment with growth factors, especially EGF. BxPC-3 pancreatic carcinoma cells and NIH3T3 ®broblasts were studied for comparison. The BxPC-3 cell line is one of the few pancreatic carcinoma cell lines without constitutive active K-Ras and without enhanced Ras activity (Yip-Schneider et al., 1999) . Our data demonstrate, that PANC-1 cells do not display constitutively activated Raf-MAPK activity, despite the mutated K-ras allele. Furthermore, PANC-1 cells retain their ability to respond to growth factors with activation of the Ras-MAPK cascade. Activation of MAPK is involved in serum-induced cell growth as well as serum-and EGF-mediated chemotaxis, as analysed by inhibition of MEK-1, the upstream activator of MAPK. Marked activation of MAPK by one growth factor alone, such as EGF, is not sucient to induce substrate-dependent or -independent cell proliferation of serum-starved PANC-1 cells, indicating that additional mitogenic stimuli are necessary for cell growth. However, EGF alone is sucient to induce cell migration, pointing towards a functional relevance of EGF in cell migration or invasion. It has previously been suggested that overexpression of the EGF receptor and the ligands EGF and TGFa is involved in autonomous proliferation of pancreatic tumor cells, including PANC-1 (Friess et al., 1996; Korc et al., 1992) . We did neither observe growth factor-independent, autonomous cell growth nor EGF-triggered proliferation of PANC-1 cells. Although growth factor requirements for proliferation of pancreatic cells are controversially discussed in the literature (Gillespie et al., 1993; Smith et al., 1987) , results similar to those presented here were described by Beauchamp et al. (1990) and Freeman et al. (1995) . In a recent report, Seuerlein et al. (1999) demonstrated that TGFa can stimulate proliferation of serum-starved PANC-1 and MiaPaCa-2 cells in a Ras-MAPK-dependent manner. We could con®rm their data concerning the MEKdependent MAPK activation by TGFa, but not with regard to the proliferative eect of TGFa, as assessed by thymidine incorporation (Table 1) and growth in soft agar (data not shown). The reasons for this discrepancy are currently unclear. n=2. Serum-starved PANC-1 and NIH3T3 cells were treated with the indicated growth factors. DNA-synthesis was determined after treatment for 36 h (PANC-1) and 24 h (NIH3T3), respectively, by [
The Ras-Raf-MAPK cascade plays a central role in transmitting growth factor-triggered signals. Watanabe and coworkers (Watanabe et al., 1996) suggested a constitutive activation of Ras protein and its downstream eectors in PANC-1 cells. In contrast, our analysis did not reveal a constitutive activation of the Ras-MAPK cascade in these cells as compared to BxPC-3 pancreatic carcinoma cells and NIH3T3 ®broblasts carrying wild-type K-ras. Transfection assays with constitutive active K-Ras (G12V) clearly demonstrated that K-Ras is able to activate MAPK in PANC-1 cells. Sequence analysis of K-Ras cDNA from PANC-1 did not reveal any additional mutations, arguing against the possibility that an altered eector site is present in the corresponding protein. Furthermore, since K-Ras bind to GST-RBD (shown in Figures 5 and 7) we conclude that lack of constitutive MAPK activity is not due to a loss of K-Ras activity.
Stimulation of Ras and MAPK in K-Ras mutated cells is not without precedent in literature. Thus, several colon carcinoma cell lines with either K-ras mutation, overexpression of K-Ras protein, or with increased Ras-GTP content maintained the ability of Ras to mediate growth factor-induced signaling leading to MAPK activation (Buard et al., 1996) . Neither the presence of K-ras mutation nor the level of Ras expression correlated with the malignant phenotype of the colon carcinoma cells, examined in that study. Reports by Seuerlein et al. (1999) and Yip-Schneider et al. (1999) likewise reported lack of constitutive MAPK activity in PANC-1 and other pancreatic carcinoma cell lines, as well as primary tumor tissue Yip-Schneider et al., 1999) . To identify which Ras isoform mediates growth factor-induced MAPK activation, we have analysed the expression and activation of individual Ras proteins. Serum-starved PANC-1 cells exhibit a marked proportion of activated K-Ras, but only the content of GTP-bound N-Ras markedly increased after growth factor addition. Thus, N-Ras is most likely the major Ras-isoform activated by receptor tyrosine kinases, especially the ligand-occupied EGF receptor in PANC-1 cells. Recently, some other reports described Ras-isoform speci®c signal transduction eects. Hamilton and Wolfman (1998) transfected ®broblasts with dierent Ras-isoforms and demonstrated that wild type N-Ras is necessary to mediate H-Ras (G12V)-induced serum-independent proliferation. N-Ras, but not mutationally activated H-Ras interacted with Raf. In contrast, the results obtained by Seuerlein et al. (1999) showed activation of H-Ras in MiaPaCa-2 and PANC-1 cells after addition of TGFa to serum-starved cells, but they did not present data about N-Ras activation. According to our results, H-Ras was barely, if at all, expressed in PANC-1 cells and was not detectable in activation experiments. Despite these dierences, all these studies point towards functional dierences of Ras isoforms in response to growth factors. Other ®ndings in support of Ras-isoform speci®c functions are embryonic lethality in mice after homozygous inactivation of K-ras, but not of H-or N-ras (Johnson et al., 1997; Koera et al., 1997) , and distinct transforming activity of Ras isoforms (Maher et al., 1995; Yan et al., 1998) .
To what extent dierent Ras isoforms regulate distinct signal transduction pathways in PANC-1 cells is currently under investigation. Recent results in our group demonstrate that the jun-N-terminal kinase/ stress-activated protein kinase (JNK/SAPK) pathway is activated by addition of growth factors or heat application, indicating that this pathway is likewise not constitutively active. Another Ras-dependent eector pathway includes phosphatidylinositol-3-kinase (PI-3-K) (Rodriguez Viciana et al., 1997) , but treatment of PANC-1 cells with the PI-3-K inhibitor wortmannin did not aect cell proliferation, cell migration, or MAPK activation by FCS or EGF, /well) were seeded in the top chamber of trans-well inserts (8 mm pore size, 12-well) in medium without supplements. To inhibit cell proliferation, cells were treated with 10 mg/ml mitomycin C 3 h before addition of growth factors (10% FCS or 100 ng/ml EGF) to the bottom chamber (solid bars). Control cells remained in DMEM without supplements (clear bar). MEK-1 inhibitor PD98059 (25 mM) was added to both chambers (hatched bars). Cells were incubated for 40 h, ®xed with paraformaldehyde and stained with hematoxylin. Non-migrated cells on the upper side of the porous membrane were wiped away. Quanti®cation (mean values+s.e.m.) of migrated cells was performed by counting three individual visual ®elds (magni®cation6100). One representative assay out of three independent experiments is shown respectively (unpublished results). In a recently published report, Grewe et al. (1999) demonstrated, that in serum-starved MiaPaCa-2 and PANC-1 pancreatic cells the FRAP-p70 S6K serine/threonine kinase pathway is constitutively active. Inhibition of this pathway by rapamycin resulted in reduced cyclin D1 expression and cell cycle progression. Positive and negative regulatory eects on proteins regulating the cell cycle by activated K-Ras in MCF-7 cells were also reported (Fan and Bertino, 1997) .
Growth factors and their receptors are not only involved in mitogenesis, but also induce cell migration and invasion (Anand- Apte and Zetter, 1997) . In some systems, these processes are also dependent on activated MAPK (Verbeek et al., 1998; Wells et al., 1998) . We demonstrate here that EGF as well as FCS caused a marked stimulation of cell migration, which was highly dependent on activated MEK. Thus, activation of MAPK by EGF via N-Ras is an essential signaling mechanism leading to cell migration. Stimulation of cell migration is a prerequisite for metastatic behavior of tumor cells. Our results thus identify the N-Ras-MAPK cascade as a signal transduction pathway involved in regulating tumor growth and metastasis in response to growth factors in pancreatic carcinoma cells. The activated K-Ras does not cause constitutive activation of the Raf-MAPK signal transduction pathway.
Materials and methods
Chemicals and growth factors
[g-32 microscope and three visual ®elds were counted for quanti®cation.
RT ± PCR analysis of Ras mRNA expression
Total RNA was extracted using the RNeasy midi kit from Qiagen (Hilden, Germany) according to manufacturer's instructions. For RT ± PCR, 10 mg of total RNA were reversely transcribed using oligo-dT primer and reverse transcriptase (Superscript, Life Technologies, Karlsruhe, Germany). cDNA was synthesized for 60 min at 378C. Complementary DNAs for each Ras isoform were ampli®ed from single-stranded cDNA by PCR using 2.5 mM MgCl 2 and 2.5 U Taq DNA Polymerase (Sigma). The ampli®cation protocols for individual Ras isoforms were as follows: 28 cycles at 948C for 1 min, 488C for 1 min for H-Ras and NRas or 428C for K-Ras4A or 4B, respectively, 728C for 1 min and a ®nal extension time of 10 min at 728C. The PCR primers were designed based on the published human cDNA sequences: H-Ras: sense 5'-GCAGGCCCCTGAGGAGC-GATG-3' (nucleotides 718 ± +3, exon 1), antisense 5'-TCAGGGAGAGCACACACTTGCAGC-3' (starting with the STOP-codon in exon 4); K-Ras4A/4B: sense 5'-GAGAGAGGCCTGCTGAAAATG-3' (nucleotides 718 ± +3, exon 1), K-Ras4A: antisense 5'-TTCTGAGGACCGA-CACACTTT-3' (nucleotides 5267546, exon 4A); K-Ras4B: antisense 5'-AAAAAGTACAAATTGTATTTA-3' (starting with the STOP-codon in exon 4B); N-Ras: sense 5'-GGTTCTTGCTGGTGTGAAATG-3' (nucleotides 718 ± +3, exon 1), antisense 5'-ACTTTAAAAGTAATCTTGTTA-CAT-3' (starting four nucleotides before the STOP-codon in exon 4). As a control, b-actin mRNA was ampli®ed from the used cDNAs using the following ampli®cation protocol: 15 cycles at 948C for 45 s, 608C for 1 min, 728C for 1.5 min and a ®nal extension time of 10 min at 728C. The PCR primers were: 5'-GCGTACCTCATGAAGATCCT=3' (sense) and 5'-GCGGATGTCCACGTCACACT-3' (antisense). The PCR products contained in 20 ml of the reaction volume were fractionated by agarose [2% (w/v)] gel electrophoresis and visualized by ethidium bromide staining. To verify the sequence of the ampli®ed PCR-products, the separated products were gel-puri®ed using the QIAquick Gel Extraction Kit (Qiagen) and directly sequenced. The K-Ras4B PCRproduct was additionally cloned in the pCR2.1 vector using the TA cloning Kit (Invitrogen, Groningen, The Netherlands) and plasmid DNA from individual clones was sequenced.
Single nucleotide primer extension (SNuPE) assay K-Ras PCR products were obtained and puri®ed as described in the preceding section and puri®ed cDNAs for wild-type KRas (G12) and mutated K-Ras (G12D) were used as SNuPE assay templates. SNuPE assays were performed as described (Moepps et al., 1999) in a ®nal volume of 10 ml containing 16Taq buer (Sigma, Deisenhofen, Germany), 20 ng of template DNA, 2 mM SNuPE primer (K-Ras: 5'-ACTTGTG-TGAGTTGGAGCTG-3', nucleotides 15 ± 34), 1 unit Taq DNA polymerase (Sigma) and 0.2 mCi of [ 32 P]dATP or [ 32 P]dGTP. After one round of ampli®cation (948C for 3 min, 608C for 1 min, 728C for 1 min) on a thermal cycler, 10 ml of sequencing gel-loading buer was added and denaturation was performed for 3 min at 948C. The samples were electrophoresed (35 mA) on a denaturing 7 M urea-15% (w/v) polyacrylamide gel, and the radiolabeled bands were visualized by autoradiography.
Expression and purification of recombinant proteins
Expression plasmids for polyhistidine-tagged wild-type mouse MEK-1 (wt MEK-1), kinase-inactive MEK-1 and kinaseinactive mouse p42 MAPK (MAPK) were kindly provided by W Ko È lch (Glasgow, UK). The kinases were expressed in E. coli BL21(DE3)pLysS and puri®ed as described by Gardner et al. (1994) .
pGEX-2T/GST-RBD expression plasmid encoding glutathione S-transferase (GST)-fusion protein of the Rasbinding domain (RBD) of Raf-1 (aa 51 ± 131) was kindly provided by JL Bos (Utrecht, The Netherlands). pGEX-2TK control plasmid for expression of GST was obtained from Pharmacia (Uppsala, Sweden). Protein expression was performed in E. coli DH5a for 2 h after expression had been induced with 0.1 mM IPTG. Bacteria were harvested and resuspended in 1/20 volume of PBS with divalent cations (8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , pH 7.4, 136 mM NaCl, 2.7 mM KCl, 1.5 mM CaCl 2 , 0.5 mM MgCl 2 , 0.5 mM DTT, 0.1 mM aprotinin, 1 mM leupeptin, 1 mM pepstatin A). Cell lysis was achieved by sonication on ice with three bursts of 1 min each. After adding 1% (v/v) Triton X-100, cells were gently stirred for 30 min at 48C. Cell debris was sedimented by centrifugation at 12 000 g for 10 min. Glycerol was added to the supernatant to ®nal concentration of 10% (v/v) and aliquots were stored at 7808C. pET23d(+)/HA-K-Ras expression plasmid was generated by PCR using sense primer encoding for a PstI restriction site, the anti-HA recognition site of the 12CA5 antibody, a NdeI restriction site before the ATG (5'-AAACTGCA-GATGTATCCTTATGATGTTCCTGATTATGCCCATAT-GACTGAATATAAACTTGTG-3') and antisense primer encoding for the last 12 nucleotides of K-Ras4B and a BamHI restriction site (5'-GGGGATCCTTACATAATTAC-3'). The HA-K-Ras PCR product was ligated as PstI/BamHI fragment into pBluescript KS (Stratagene) and thereafter as EcoRV/NotI fragment into pET23d(+)/NcoI-Klenow/NotI (Novagen). pET23d(+)/HA-H-Ras and HA-N-Ras expression plasmids were generated by amplifying H-Ras and NRas coding sequences (kindly provided by Y Kloog, Tel Aviv, Israel and C Block, Dortmund, Germany) using the following PCR primers H-Ras: sense 5'-GGCATATGACA-GAATACAAGCTTGTTGTGGTGGGCG-3', H-Ras antisense: 5'-CCCCGGGATCCTTAGGAGAGCACACACTTT-3'; N-Ras: sense 5'-CCCCGGGCTGCAGCATATGACT-GAGTACAAACTGGT-3', N-Ras: antisense 5'-CCCCGG-GATCCTTACATCACCACACATGGG-3'. PCR products were digested with NdeI/BamHI and cloned into pKS/HA-K-Ras thereby replacing the K-Ras sequence. Cloning into pET23d(+) was performed as described for HA-K-Ras. Recombinant Ras proteins were expressed in E. coli BL21(DE3) by adding 0.1 mM IPTG to induce protein expression and further growth for 3 h. The bacterial pellet was resuspended in 1/10 volume of ice-cold lysis buer (20 mM Tris/HCl, pH 7.2, 100 mM NaCl, 5 mM MgCl 2 , 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl¯uoride). Cell lysis was achieved by sonication on ice with three bursts of 1 min each. Cell debris was sedimented by centrifugation at 17 000 g for 30 min and the supernatant was stored at 7808C.
Ras assay
The GTP-bound form of Ras was determined by using GST-RBD as an activation-speci®c probe for endogenous Ras-GTP (de Rooij and Bos, 1997) . Con¯uent cells were serumstarved for 16 ± 20 h in minimal medium (DMEM+0.1% (v/v) FCS) and stimulated with 30 ng/ml EGF in minimal medium. Cells (1 ± 2610 7 /100 mm dish) were washed twice with PBS without divalent cations and lysed in 500 ml Ras-RIPA buer (50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 0.5% (v/v) sodium deoxycholate, 1% (v/v) NP-40, 0.1% (w/v) sodium dodecyl sulphate, 1 mM leupeptin, 1 mM phenylmethylsulfonyl¯uoride). The cell lysate was cleared by centrifugation at 15 800 g for 15 min at 48C and protein concentration was determined by the bicinchoninic acid assay (Pierce; Rockford, IL, USA). Glutathione-Sepharose 4B (25 ml) (Pharmacia; Uppsala, Sweden) was washed with Ras-RIPA-buer and preincubated with 150 ml GST-RBD extract for 30 min at room temperature. Cell lysate (1 mg) was added to washed beads and incubated by end-over-end rotation for 2 h at 48C. Sepharose beads were collected by centrifugation, washed ®ve times with Ras-RIPA buer, and resuspended in SDS-gel loading buer (160 mM Tris/HCl, pH 8.8, 800 mM sucrose, 4 mM EDTA, 2% (w/v) SDS, 1 mM DTT, 0.1% (w/v) bromophenol blue). Proteins were separated on a 12.5% SDS-polyacrylamide gel (568 cm) and subsequently transferred to an Immobilon-P (PVDF) membrane (Millipore Corporation; Bedford, MA, USA). Protein transfer and equal loading was controlled by Ponceau S staining. Precipitated endogenous Ras was detected using the monoclonal pan-Ras antibody (Ab-3) (16 h, 48C) and peroxidase-coupled goat anti-mouse antiserum (1 h, RT). Immunoreactive proteins were visualized using the ECL Western blotting detection system (Pierce; Rockford, IL, USA). Densitometric analysis were performed by using the SigmaGel gel analysis software (Jandel Corporation). To detect isoform-speci®c Ras activation, serum-starved PANC-1 cells were either stimulated with 10% (v/v) FCS or 30 ng/ ml EGF for 5 min and lysate was prepared as described before. Ras assays were performed using 5 mg cell lysate, 50 ml Glutathione-Sepharose 4B and 250 ml GST-RBD extract. Bound proteins were resuspended in SDS-gel loading buer, separated on 16.5% tricine-SDS-polyacrylamide gel (22613.5 cm) (Schagger and von Jagow, 1987) and transferred to nitrocellulose. Precipitated endogenous Ras-isoforms were detected using the following Ras-isoform speci®c antibodies: c-H-Ras (Ab-1), H-Ras (F235), c-K-ras (Ab-1), K-Ras (F234), c-N-Ras (Ab-1), each diluted 1 : 100, peroxidase-coupled goat anti-mouse antiserum and ECL Western blotting detection system. To verify the speci®city of the antibodies, recombinant HA-tagged H-Ras, K-Ras or N-Ras was immunoprecipitated from transformed E. coli BL21(DE3) using 30 ml protein G-agarose, 4 ml anti-HA (12CA5) antibody and 400 mg of bacterial lysate. The precipitates were used as controls in Western blot analysis.
Raf assay
Con¯uent cells (100 mm dish) were serum-starved over night in minimal medium (DMDM+0.1% (v/v) FCS) and stimulated with growth factor for 5 min. Cells were washed twice with ice-cold PBS without divalent cations and lysed by scraping into 500 ml RIPA buer (50 mM Tris/HCl, pH 7.2, 150 mM NaCl, 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 2 mM sodium orthovanadate, 25 mM b-glycerophosphate, 10 mM sodium pyrophosphate, 400 mM aprotinin) and homogenization in a Dounce homogenizer. Cell debris was removed by centrifugation and protein concentration was determined by the bicinchoninic acid method. For immunoprecipitation, 2.5 ml of anti-c-Raf-1 antiserum was precoupled to 25 ml protein A-agarose and cRaf-1 was precipitated from 2 mg cell lysate for 2 h at 48C. The precipitate was washed twice with RIPA and twice with Raf kinase buer (20 mM PIPES/KOH, pH 7.0, 10 mM MnCl 2 , 5 mM aprotinin) and resuspended in 30 ml kinase buer. One third of the sample was diluted with SDS-gel loading buer. Proteins were separated on 7.5% SDSpolyacrylamide gel and transferred to nitrocellulose (Schleicher & Schuell, Dassel, Germany) . c-Raf-1 was detected by immunoblot analysis using c-Raf-1 antiserum and peroxidasecoupled anti-rabbit antibody for detection with ECL reagent. The remaining immunoprecipitate was assayed for c-Raf-1 kinase activity by adding 2 mM ATP, 0.5 ml recombinant wt MEK-1, 1.5 ml recombinant kinase-inactive MAPK, 2.5 mCi [g- 32 P]ATP (5000 Ci/mmol) and incubation for 30 min at 378C. The kinase reaction was terminated by addition of SDS-gel loading buer and subsequent boiling. Proteins were separated on 7.5% SDS-polyacrylamide gel and phosphorylated products were visualized by autoradiography.
MEK assay
MEK activity was determined as described for Raf with the following modi®cations. The MEK-1 inhibitor PD98059 was dissolved in assay medium and added to the cell culture medium 15 min prior to growth factor addition. Control cells were treated with solvent. Immunoprecipitation was carried out with 4 ml polyclonal anti-MEK-1 antiserum (C-18), 25 ml protein A-agarose and 1 mg of RIPA cell extract. The analysis of MEK-1 activity was performed as described for Raf except for using 15 mM Tris/HCl, pH 7.2, 15 mM MgCl 2 , 1 mM DTT as kinase buer and 5 ml recombinant kinaseinactive MAPK as phosphorylation substrate. The amount of immunoprecipitated MEK-1 was analysed by immunoblotting.
MAPK assay
Cell stimulation and lysis were carried out as described for Raf, treatment with the MEK-1 inhibitor as speci®ed for MEK. MAPK was immunoprecipitated from cell extract (0.5 mg protein) for 2 h at 48C using 25 ml protein A-agarose and 7 ml anti-ERK 2 antibody (C-14). The washed precipitate was resuspended in 30 ml kinase buer (15 mM Tris/HCl, pH 7.2, 15 mM MgCl 2 , 1 mM DTT). The reaction was started by adding 2 mM ATP, 30 mg MBP peptide (APRTPGGRR), and 2 mCi [g- 32 P]ATP (5000 Ci/mmol), and the mixture was incubated for 10 min at 378C. The samples were spotted onto P81 phosphocellulose ®lters. The ®lters were washed three times in 180 mM phosphoric acid, drained by submersion in acetone and bound radioactivity was measured by determination of Cerenkov radiation. Unspeci®c phosphorylation of the MAPK substrate was quanti®ed by MBPphosphorylation in kinase buer alone. One third of the immunoprecipitate was analysed by 7.5% SDS ± PAGE and immunoblotting using the anti-ERK 2 antibody (C-14) and the ECL detection system.
HA-MAPK activity in transfected cells
cDNAs of wild-type K-Ras (G12) and mutationally activated K-Ras (G12V) were ligated into pcDNA3.1 expression vector (Invitrogen, Groningen, The Netherlands). PANC-1 cells (3610 6 cells/100 mm dish) were cotransfected by liposomemediated DNA transfer utilizing 40 ml DMRIE-C reagent (Life Technologies, Karlsruhe, Germany), 8 mg of pcDNA3/ HA-MAPK (kindly provided by JS Gutkind, Bethesda, USA) and 8 mg of pcDNA3.1/K-Ras (G12) or pcDNA3.1/K-Ras (G12V), respectively, according to the manufacturer's instructions. After 6 h incubation, transfection medium was replaced by growth medium, the cells were further incubated for 40 h at 378C, 10% CO 2 and then serum-starved for an additional 20 h. Cells were lysed as described for MAPK assay. For immunoprecipitation of HA-tagged MAPK out of 1 mg of cell lysate, 4 ml anti-HA (12CA) antibody and 30 ml protein G-agarose were used. Determination of HA-MAPK activity was performed as described for endogenous MAPK in the previous section.
